My initial comments.
DCB's main achiement so far is creating the very impressive Clinical Advisory Board.
Recruitment in Israel is disappointingly slow given the good results in the previous phase. At this rate, 9 patients won't be treated in the P2 this year.
Several preclinicals were conducted in the USA. Apart from the North Carolina cardioprotection one, that's news to me. Maybe I missed it. Anyway, that raises awareness in the USA. However, they were inconclusive. That's the first time this has happened. I would have liked to be told about these setbacks in real time.
The word "FTO" doesn't appear in the body of the announcement, only in the "About RAC" section.
Hold, Buy
Ann: Quarterly Activity Report & Appendix 4C, page-14
-
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.81 |
Change
-0.010(0.55%) |
Mkt cap ! $307.3M | |||
| Open | High | Low | Value | Volume |
| $1.83 | $1.84 | $1.78 | $271.2K | 150.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 349 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |